Fgf9 from tuft cells is predicted to target Fgfr1 on fibroblasts in both PRN and PRT, and epithelial cells through Fgfr1 or Fgfr2 in PRT cancer model (Fig. 7B, Table S5). Here, FGFR2 is linked to cancer.